Angiosyn's Series A Round

Angiosyn raised a round of funding on April 05, 2003. Investors include Alta Partners.

Angiosyn, Inc. is a biopharmaceutical company developing novel proprietary biologics for controlling angiogenesis. The company's initial therapeutic indication is for ophthalmic diseases, such as macu…

Articles about Angiosyn's Series A Round: